Verified Nov 2026
Electronics & Software
·
Saint Louis, Missouri
·
Since 1990
Stereotaxis is a medical technology company headquartered in Saint Louis, Missouri, founded in 1990 and publicly traded under the ticker STXS. It employs roughly 100 to 200 people and makes robotic magnetic navigation systems for minimally invasive endovascular procedures, serving the medical sector. In 2026 it announced and then completed the acquisition of Robocath, a French catheter robotics company, extending its portfolio in interventional procedures.
Stereotaxis at a glance
Revenue
32.4M
Employees
100-200
Founded
1990
Headquarters
Saint Louis, Missouri
Ownership
Publicly traded (AMEX: STXS)
Import activity
5
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
5
Named foreign suppliers
4
Top origins
South Korea · Singapore · China · Netherlands
Shared foreign counterparties do not establish that these companies buy from Stereotaxis.
What this tells a buyer
Stereotaxis announced a definitive agreement to acquire Robocath on April 15, 2026, and completed the acquisition on July 9, 2026.
The company's product lines include its Genesis and Odyssey robotic magnetic navigation systems for image-guided catheter procedures, and its catalog lists electronics products.
Stereotaxis reports its annual and quarterly financial results publicly, and its company profile describes systems installed in more than 100 hospitals worldwide.
Source: US customs bill-of-lading records and public filings · Last verified Nov 05, 2026
Overview
Stereotaxis is a medical technology company headquartered in Saint Louis, Missouri, founded in 1990 and publicly traded under the ticker STXS. It employs roughly 100 to 200 people and makes robotic magnetic navigation systems for minimally invasive endovascular procedures, serving the medical sector. In 2026 it announced and then completed the acquisition of Robocath, a French catheter robotics company, extending its portfolio in interventional procedures.
At a glance
Attribute | Detail |
|---|---|
Founded | 1990 |
Headquarters | Saint Louis, Missouri |
Employees | 100-200 |
Revenue | 32.4M |
Ownership | Publicly traded (AMEX: STXS) |
Primary capability | Electronics & Software |
What Stereotaxis makes
The company's product lines include its Genesis and Odyssey robotic magnetic navigation systems for image-guided catheter procedures, and its catalog lists electronics products.
Products and capabilities described on the company's own site include LED, Electronics (source: stereotaxis.com).
Trade and customs footprint
Stereotaxis announced a definitive agreement to acquire Robocath on April 15, 2026, and completed the acquisition on July 9, 2026. US customs bill-of-lading records list 5 inbound shipments across 4 foreign suppliers, with top origins including South Korea · Singapore · China · Netherlands.
Latest developments
2026-10-30 — Canon Medical and Stereotaxis Collaborate to Advance Robotic Electrophysiology | Stereotaxis Inc. (stereotaxis.com)
2026-08-11 — Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates | Stereotaxis Inc. (stereotaxis.com)
2026-07-09 — Stereotaxis Completes Acquisition of Robocath | Stereotaxis Inc. (stereotaxis.com)
2026-04-15 — Stereotaxis Announces Definitive Agreement to Acquire Robocath | Stereotaxis Inc. (stereotaxis.com)
2026-03-09 — Stereotaxis Reports 2025 Full Year Financial Results | Stereotaxis Inc. (stereotaxis.com)
2025-10-13 — Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias | Stereotaxis Inc. (stereotaxis.com)
Company details
Stereotaxis reports its annual and quarterly financial results publicly, and its company profile describes systems installed in more than 100 hospitals worldwide. Stereotaxis was founded in 1990, has an estimated 100-200 employees, and is headquartered in Saint Louis, Missouri.
Frequently asked questions
What does Stereotaxis make?
Stereotaxis is a medical technology company headquartered in Saint Louis, Missouri, founded in 1990 and publicly traded under the ticker STXS. It employs roughly 100 to 200 people and makes robotic magnetic navigation systems for minimally invasive endovascular procedures, serving the medical sector. In 2026 it announced and then completed the acquisition of Robocath, a French catheter robotics company, extending its portfolio in interventional procedures.
Where is Stereotaxis headquartered?
Stereotaxis is headquartered in Saint Louis, Missouri (710 N Tucker Blvd, Saint Louis, Missouri, 63101-1112).
When was Stereotaxis founded?
Stereotaxis was founded in 1990.
How big is Stereotaxis?
Stereotaxis has an estimated 100-200 employees, with revenue in the 32.4M range.
Is Stereotaxis publicly traded?
Publicly traded (AMEX: STXS). Public financial figures are drawn from its filings.
Does Stereotaxis import from overseas suppliers?
US customs bill-of-lading records show 5 inbound shipments for Stereotaxis, with top origins including South Korea · Singapore · China · Netherlands.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.